Palvella Therapeutics PVLA Current ratio

Current ratio at other companies

Relay Therapeutics, Inc.RLAY

18.3×-2.7×

Viridian Therapeutics, Inc.VRDN

16.9×+5.9×

ANI PharmaceuticalsANIP

2.9×+0.4×

Arcutis Biotherapeutics, Inc.ARQT

2.9×-0.3×

Zevra Therapeutics, Inc.ZVRA

5.2×-2.7×

Eton Pharmaceuticals, Inc.ETON

1.2×-0.8×

FAQ

What is Palvella Therapeutics's current ratio?

Palvella Therapeutics (PVLA) reported current ratio of 28.9× in Q1 2026.

How has Palvella Therapeutics's current ratio changed year-over-year?

Palvella Therapeutics's current ratio increased by 226.6% year-over-year, from 8.8× to 28.9×.

What is the long-term trend for Palvella Therapeutics's current ratio?

Over 5 years (2020 to 2025), Palvella Therapeutics's current ratio has grown at a 8.7% compound annual growth rate (CAGR), from 3.4× to 5.2×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.